Clinical Trials Directory

Trials / Unknown

UnknownNCT05177380

Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Systemic sclerosis is a rare autoimmune disorder characterized by microangiopathy, activation of the immune system, and sclerosis of tissues including the skin. Facial involvement is frequent and disabling. It causes significant functional and aesthetic discomfort, and a major deterioration in quality of life. It results in a loss of suppleness of the skin and subcutaneous tissues, dysfunction of the temporomandibular joint, peribuccal rhagades, microstomia, and dry mouth causing difficulties in mouth opening, feeding, dental care, and weight loss. Facial involvement in systemic sclerosis can be assessed using the Mouth Handicap in Systemic Sclerosis (MHISS) score, a validated patient questionnaire assessing the functional and aesthetic consequences of systemic sclerosis on the face. Although common and disabling, facial involvement is underestimated and poorly managed. Immunosuppressive and/or anti-fibrosis drugs are not very effective. Facial rehabilitation could significantly improve the mouth handicap but facial rehabilitation is not currently performed in standard care in systemic sclerosis patients. The aim of the study is to evaluate the efficacy of a personalized rehabilitation program vs standard care in facial involvement of systemic sclerosis patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREPersonalized rehabilitation program of facial involvement in systemic sclerosisPersonalized rehabilitation program of facial involvement in systemic sclerosis
OTHERDelivery of a standard prescription for facial rehabilitationDelivery of a standard prescription for facial rehabilitation

Timeline

Start date
2022-09-01
Primary completion
2024-04-01
Completion
2024-04-01
First posted
2022-01-04
Last updated
2022-08-18

Source: ClinicalTrials.gov record NCT05177380. Inclusion in this directory is not an endorsement.